Estrella Immunopharma- Warrants (29/09/2028) Overview
Estrella Immunopharma- Warrants (29/09/2028) Discounted Cash Flow
DCF Analysis for ESLAW.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.04
Current Fair Value
$0.04
↓ 70.6% Downside
Overvalued by 70.6% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison